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ABSTRACT 
Requirement of Osr1 in Second Heart Field (SHF) for Proper Outflow Tract (OFT) Alignment  
 
Naomi McCauley 
Department of Veterinary Medicine & Biomedical Sciences 
Department of Nutrition and Food Science 
Texas A&M University 
 
Research Advisor: Dr. Linglin Xie 
Department of Nutrition and Food Science 
Texas A&M University 
 
Congenital heart disease (CHD) is current in 1/3 of all birth defects and has the 
prevalence of 1 in 1000 births.1 1/3 of all CHDs consist of cardiac outflow tract (OFT) defects.1 
Despite its high prevalence, the genetic ontogeny of CHD has much to be studied. Knocking out 
Osr1, a gene encoding for a putative transcription factor containing four C2H2-type zinc finger 
motifs, is reported to cause heart defects including atrioventricular septal defects (AVSDs) in 
mice2-4 while its involvement in OFT development has yet to be studied. Osr1 is expressed in the 
second heart field (SHF), overlapping the expression of Gli1, an important modulator of sonic 
hedgehog (Shh) signaling pathway.4 Shh-signaling has been reported to contribute to the OFT 
development.5 Our preliminary study has shown that Osr1 deletion causes OFT defects including 
DORV and OA—suggesting its role in OFT alignment. We hypothesize that Osr1 is required in 
the SHF and Shh-signaling for proper OFT alignment. We will use a Cre-lox cell-specific KO 
technique to create embryos with Osr1 specific KO in SHF cells and Shh-receiving cells. We 
expect to observe high percentages of OFT misalignment including DORV and OA in embryos 
with Osr1 specific KO in SHF cells and Shh-receiving cells. This study will provide information 
which cell lineage is required for Osr1 in OFT development. 
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NOMENCLATURE 
 
CHD  Congenital heart disease 
OFT  Outflow tract 
AVSD  Atrioventricular septal defects 
SHF  Second heart field 
Shh  Sonic hedgehog 
DORV  Double outlet right ventricle 
OA  Overriding aorta 
VSD  Ventricular septal defect 
CNC  Cardiac neural crest 
PHF  Primary heart field  
NCC  Neural crest cells 
EMT  Epithelial-mesenchymal transformation 
E#  Embryonic stage # 
Hh  Hedgehog 
GIFM  Genetic inducible fate mapping 
KO  Knockout 
SpM  Splanchnic mesoderm 
ASD  Atrial septal defect 
TM  Tamoxifen 
ER  Estrogen receptor 
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CHAPTER I 
INTRODUCTION 
 
Background and Significance  
Congenital Heart Disease (CHD)1 is one of the most common birth defects as it 
constitutes 1/3 of all birth defects with an occurrence of nearly 1 in 1000 live births.1 Cardiac 
outflow tract (OFT) defects account for nearly 1/3 of CHDs and causes significant morbidity and 
mortality of children and adults.1 Despite its common occurrence, the genetic ontogeny of OFT 
has yet to be fully elucidated. The cardiac OFT is formed through complex interactions of 
multiple cell types within the looped heart and populations of invading extra-cardiac cells. A 
variety of OFT defects result from the incorrect morphogenetic patterning occurring at the 
arterial extremity of the heart which is known to be essential to the formation of independent 
pulmonary and systemic circulations in vertebrates.1 Because of the complex coordination of 
extra-cardiac progenitor populations in location and timeframe, OFT is highly susceptible to 
congenital defects.  
Variations of OFT Defects 
 Double outlet right ventricle (DORV) and overriding aorta (OA) (Figure 1) are both 
common types of OFT anomalies. In a normal heart and OFT, the aorta and pulmonary trucks are 
separate and exit fully divided left and right ventricles respectfully.6 In DORV, the aorta and 
pulmonary trunk exit the right ventricle together and the interventricular septum remains open 
resulting in interventricular septal defect (VSD). In OA the aorta is located on top of the VSD.  
 
 6 
 
Figure 1.  
Schematics of normal and two types of OFT defects, DORV and OA are shown.1 
 
DORV and OA differ from other OFT defects in that the aorta and pulmonary trunk are 
fully separated. However, the abnormality is prevalent in the incorrect alignment over the right 
ventricle. Although the cellular, molecular, and genetic basis of OFT development is fully 
elucidated, the ontology of proper OFT alignment is still unclear. This study is significant as it 
will be investigating the genetic elements involved in proper OFT alignment.  
Genesis of OFT 
 Mammalian OFT conduit is consisting of migratory progenitor cells, such as cardiac 
neural crest (CNC), primary heart field (PHF), and second heart field (SHF) cells. These 
progenitor cells generate endocardial and myocardial cells. Precise spatiotemporal regulation and 
multiple lineage signaling are required during extra-cardiac colonization of the of the OFT from 
distinct embryonic regions take place for normal OFT development.1  
PHF Lineage   
The very first form the primeval heart can be described as a single linear heart tube made 
of paired lateral pre-cardiac mesoderm of the PHF.1 The paired lateral pre-cardiac mesoderm of 
PHF later contributes to the formation of the left ventricle and portions of the atria.  
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CNC Lineage 
 Neural crest cell (NCC) derivatives are indispensable in OFT remodeling,1 septation, and 
arrangement of the trunks. CNC is a subset of neural crest that originate from the lower 
hindbrain and plays a crucial role in normal heart development.1 Epithelial-mesenchymal 
transformation (EMT) allows CNC to migrate to the aortic sac and OFT truncal cushions around 
embryonic stage 9 (E9) in mice (days 20-22 in human) and onwards until E11 giving rise to the 
aorticopulmonary septa.1 The aortic sac is a dilated, non-muscular, vascular channel lined by 
endothelial cells connecting the primitive OFT and arch arteries. The OFT septum separates the 
systemic and pulmonary circulation. This structure is originally like an extending shelf, then 
goes through OFT elongation and grows its way to meet the OFT cushions.1 OFT rotation occurs 
with simultaneous shortening and shift to a medial position above the ventricular septum, 
meaning, the septation of OFT occur as the aorticopulmonary septum and growing endocardial 
cushions fuse due to increased CNC colonization of truncal cushions. Failure of proper OFT 
rotation while OFT elongation takes place can lead to OFT defects, such as DORV and OA. 1 
CNC also play a role in the development of the aortic arch and atrial wall by contributing to the 
vascular smooth muscle cells of those structures. 
SHF Lineage 
The right ventricle, ventricular septum, and OFT precursor is then derived from 
cardiomyocytes from the SHF pharyngeal mesoderm that migrate into the heart at E8 in mice,1 
while third week in humans.1 Different segments of the OFT is formed by different progenitor 
cells –from within the loop shaped heart and from extra-cardiac cells, such as CNC and SHF 
cells, that migrate from outside the heart to within. Part of the OFT precursor is formed by the 
SHF that grows out of the cardiac crescent to the arterial end of the developing left ventricle. 1 
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Rightward looping and elongation of the OFT occur with the addition of SHF-derived 
myocardial precursors from pharyngeal mesoderm.1 As this occurs, simultaneously, the SHF 
progenitor proliferation is progressively inhibited while the cardiomyocyte lineages are 
activated. Impaired SHF proliferation, primarily caused by the failure of SHF to colonize the 
arterial extremity of the heart tube, can lead to underdevelopment of the OFT. Gene deletions 
that are highly expressed in SHF, such as Mef2c,1 has shown to result in abnormalities during 
heart development, such as failure in elongation and looping of the heart tube and 
underdevelopment of the right side of the heart, atria, and OFT.  
Endocardial Cell Lineage 
 Derived from cardiac mesoderm, endocardial cells are endothelial cells that line the 
myocardium of the heart.1 The endocardial cell lineage plays two important roles in OFT 
morphogenesis: one in endocardial cushion development and second as a regulator of OFT 
myocardial proliferation.1 The endocardium goes through EMT to produce mesenchymal cells 
that migrate for acellular endocardial cushion to prevent retrograde blood flow.1 After the 
cushion and septation of the OFT fuse, the truncal OFT endocardial cushion further transforms 
into aortic and pulmonary valves.1 Here, truncal OFT (CNC-derived) refers to the portion of the 
OFT distant from the heart making it closer to the pharyngeal arches.1 
Hh Signaling 
Hedgehog (Hh)-signaling has shown to have an important role in multiple aspects of the 
heart development. While critical in left-right symmetry in mice,7-9 Hh-signaling is also required 
in CNC survival and pharyngeal endoderm. A study that disrupted the the Hh-signaling in CNC 
by crossing Wnt-cre line with Smo-flox line producing mutant embryos all showed OFT defects, 
such as DORV.10,11 Additionally, but no less, Hh-signaling was shown to mark a subset of 
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cardiac progenitors specific for atrial septum and pulmonary trunk in the SHF of the mouse 
heart.11 Hh-receiving progenitor cells were marked in SHF between E8 and E10,11 using genetic 
inducible fate mapping (GIFM) with Gli1: CreERT2. Atrial septum and pulmonary trunk 
progenitors migrate into the heart after receiving Hh signals outside of the actual developing 
heart.11 The atrial septum progenitor cells receive Hh signaling in the posterior SHF mesoderm 
and migrate to the atrial septum at E9.5 and E11.5. 11 As for the cardiac OFT, the progenitor cells 
receive Hh-signaling in the anterior SHF mesoderm around E8 and E10 in the pharyngeal 
mesoderm and migrate into the pulmonary artery between E9.5 and E11.5.11 Sonic hedgehog 
(Shh) signaling in the SHF, was shown to be required in the pulmonary endoderm for 
atrioventricular septation. While Hh-signaling is known for differentiating atrial septum and 
pulmonary trunk cardiac progenitors from posterior and anterior SHF respectively, Shh-signaling 
is required to induce Hh-signaling, which in turn, specifies atrial septum progenitor cells from a 
subset of atrial progenitors. This showed that Hh-signaling is required in the SHF during a 
critical time window for proper OFT development while Shh-signaling being crucial to initiating 
the Hh-signaling itself.  
Osr1 
Osr1, a gene encoding for a putative transcription factor containing four C2H2-type zinc 
finger motifs, when knocked out are reported to cause atrioventricular septal defects (AVSDs) in 
mice2-4. Previous studies have shown that Osr1 is a downstream target of Tbx5, creating the 
Tbx5-Osr1 complex, working simultaneously with Tbx5-Hh-signaling, regulates the cell cycle 
progression and proliferation of SHF cardiac progenitor cells that take role in cardiac septation. 
2,3,12 While Osr1 is known to contribute in regulating atrial septation, Osr1 involvement in OFT 
development is yet to be fully elucidated.  
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Preliminary Studies on Osr1 
Previous studies that used in-situ hybridization and immunohistochemistry showed high 
expression of Osr1 at E9.5 and E10.5 within the dorsal mesocardium, but not in the 
endothelium.2,12 Using GIFM, a previous study showed that Osr1 also contributes to atrial 
septum progenitors between E8.0 and E11.0.2 Osr1 knockout (KO) resulted in high occurrences 
of AVSDs and OFT misalignment, including DORV and OA, suggesting that Osr1 contributes to 
OFT alignment.2,3 Refer to Figure 2, where mice embryos at E14.5 showed a normal phenotype 
with Osr1 knockdown and showed abnormalities when Osr1 was knocked out. When OFT 
misalignment was further investigated at E11.5, at which OFT is yet to be separated but has 
begun its rotation for two days, OFT in Osr1 KO embryos had abnormal rotation, suggesting that 
Osr1 is involved in OFT alignment through the process of its rotation.2,3 Osr1deletion also 
caused a decrease in number of proliferating cells in the SHF at E10.5, resulting in shortened 
SHF splanchnic mesoderm (SpM) between the outflow and inflow tract;2 suggesting its 
involvement in SHF patterning. Evaluation of SHF cells using IHC staining showed that Osr1 
KO mice embryos had 53.7% fewer mitotic cells, suggesting that Osr1 is involved in SHF cell 
proliferation.2 A significant decrease in Smo expression, a Shh-signaling pathway modulator, in 
the pSHF of mice embryos with Osr1 KO ate E9.5 was found, in turn suggesting the role of Osr1 
in Shh-signaling regulations.2 The dosage of Osr1expression effected the Hh-signaling pathway 
positively during E8 to E10.5.3  
 11 
 
Figure 2. Image of normal phenotype with Osr1 knockdown and abnormalities with Osr1 KO. 
Picture A, B, C show normal phenotypes when Osr1 is knocked down. In picture A, the 
interatrial septum fully separates the left and right atrium. In picture B, the aorta is correctly 
connected to the left ventricle. In picture C, the aorta is completely disconnected from the right 
ventricle when the pulmonary trunk is connected to the right ventricle. Pictures D through I show 
abnormalities that occurred when Osr1 was knocked out. In picture D and G, the interatrial 
septum fails to fully separate the left atrium and the right atrium resulting in an atrial septal 
defect (ASD). In picture E, the aorta is incorrectly positioned over the right ventricle, resulting in 
a DORV. In picture H, the aorta is located above a VSD, resulting in a OA. In picture F and I, 
the aorta is fails to fully separate from the right ventricle when the pulmonary trunk is visualized 
to be leaving the right ventricle; which is also a characteristic for both DORV and OA.  
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Rationale 
Beginning around E8, additional mesenchymal cells migrate to the anterior side of the 
heart from the SHF15-19, and populate the OFT. Subsequently, these endocardial cells and 
endothelial cells that line the interior of OFT and go through EMT to make the endocardial 
cushions. In turn, the endocardial cushions form the OFT septum with the migrating CNC. 
Failure of SHF cell migration to the arterial pole of the heart commonly results in shortened OFT 
that leads to arterial pole misalignment1,20,21. Previous studies have shown that Osr1 is strongly 
expressed in the SHF and contribute to the pulmonary trunk between development stages E9.5 
and E10.5.2,12 KO of Osr1 also resulted in SHF proliferation defects, shortened SHF SpM, and 
OFT misalignment: which all suggested that Osr1 plays an important role in SHF in turn 
effecting OFT development.  
Previous studies have indicated Osr1 to be essential to the collaborative work of Tbx5-
Osr1 complex and Tbx5-Hh-signaling in regulating the cell cycle progression and proliferation 
of SHF cardiac progenitor cells that take role in cardiac septation.2,3,12 The knockdown of Osr1 
resulted in decreased Smo expression, a Shh-signaling pathway modulator, in the pSHF. This 
suggested that Osr1 might have a role in Hh-signaling within SHF.3 
Innovation 
Despite the high prevalence of OFT anomalies, little is known about the OFT alignment 
and DORV. The preliminary data show that Osr1 is involved in OFT alignment; and this 
proposed study aims to clarify in which cell lineage Osr1 is required for normal OFT alignment, 
specifically, by looking into the role of Osr1 in SHF cell lineage and Hh-signaling during OFT 
development. This study will add new details to the multi-gene, lineage, time-point regulated 
process of the morphogenesis of OFT alignment using Cre-lox recombinase technique, allowing 
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for tissue and time specific KO of Osr1 in SHF cells (Mef2cAHF: Cre) and Shh-receiving cells 
(Gli1: Cre) in mice embryo hearts.  
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CHAPTER II 
METHODS 
 
Study Design 
In order to define a clear map to determine if Osr1 is required in SHF for OFT alignment, 
a cre-lox recombinase technique will be utilized to achieve a tissue specific KO of the Osr1 in 
SHF and Shh-receiving cells.  Mice embryos with Osr1 deletion in Shh-receiving cells (Gli1: 
Cre) and SHF cells (Mef2cAHF: Cre) will be created using Cre-lox recombinase technique. The 
overall timeline of the mice treatments and processing can be seen in the Figure 3. 
 
Figure 3. Timeline of mice treatments and processing.  
  
Mouse Husbandry 
General Mouse Care 
Full length of mice gestation is about 18.5 to 21 days with its litter size ranging from 2 to 
12 or more.22 We will be weaning mice at approximately 21 days after birth. Gender separation, 
tagging of the ear, and tail sample collection is conducted for genotyping at the time of weaning. 
Productive breeding of mice begins between the 5th to 8th week until 7 or 8 months of age.22 To 
 15 
optimize the breeding conditions, female mice that are raised for the purpose will be mated 
starting 6 weeks old while male mice will be mated starting 8 weeks.  
Hormone Priming 
Hormone priming for female mice will induce superovulation which will increase the 
number of fertilized embryos for analyzing. Female mice (6 weeks old ~), are injected 
intraperitoneally with 0.1 mL (50 IU/ 1mL) of pregnant mare serum, and with 0.1 mL (50 IU/ 1 
mL) of human chorionic gonadotropin three days later, then immediately placed in a breeding 
cage with the appropriate stud male (8 weeks old~). Fertilization will take place approximately 
12 hours later when the ovulation occurs.  
Cre-lox Recombinase 
Cre-lox technique is a two component system consisting of Cre recombinase and 2 loxP 
sites. LoxP sites are 34 base pairs within the DNA that sandwich a specific sequence. Cre 
recombinase is a site-specific enzyme that catalyzes recombination of the specific sequence 
between the two loxP sites. The sequence flanked by the two loxP sites is often referred to as the 
“floxed” sequence. The location and orientation of the loxP site determines the type of 
recombination that takes place – deletion (when the two loxPs are in series in the same 
direction), inversion (when the two loxPs are in series in the opposite direction) or translocation 
(when the two loxPs are parallel). In this experiment we will be deleting the Osr1 sequence in 
SHF and atrial septum progenitors.  
Optimal Breeding Scheme for Breeding Target Genotype Mice 
In order to breed mice for tissue-specific deletion, two generations of breeding (25% 
homozygous for targeted gene KO) is recommended to optimize chances of target genotyped 
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mice. Genotype for a Osr1 knockdown mouse will be heterozygous flox; Cre. Tissue-specific 
deletion or KO of a genotype will be homozygous lox-deleted; Cre.  
Tamoxifen Induction 
The type of Cre-recombinase used for Shh-receiving cells (Gli1: Cre ) is tamoxifen (TM) 
dependent. This is because the Cre recombinase is combined with a gene encoding the estrogen 
receptor (ER). Thus, this particular Cre-recombinase is called CreER. The ER and Cre fuse 
together to bind the chemical TM, a type of estrogen antagonist, instead of the endogenous 
estrogen present in the mice.23 Before binding to its ligand, CreER is in the cytoplasm unable to 
enter the cell nucleus where the loxP sites present.23 Upon injection of the TM, the CreER then 
crosses over the nucleus membrane to catalyze recombination of the DNA between the two loxP 
sites.23 Therefore, CreER allows control of time, and tissue specific gene intervention.23 TM 
activates expressions 12 hours after injections while its effect lasts 36 hours.13,14 In this 
experiment, Osr1 KO in Shh-receiving cells (Gli1: Cre), TM will be injected at E8.5 and E9.5 as 
Hh-signaling is known to take place between E8 and E10. By inducing the KO of Osr1 during 
known expression time-frames of SHF cell proliferation and Hh-signaling, time and cell-line 
specific involvement of Osr1 can be investigated. 
Euthanasia 
The pregnant female mice will then be sacrificed using a CO2 chamber between 13:00 
and 15:00 of the 14th day of pregnancy to collect the embryos at embryonic stage E14.5. CO2 
will be administered until 1 minute after the breathing has stopped continued with cervical 
dislocation to confirm euthanasia is successful and assuring that the IACUC guidelines are 
followed.  
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Microdissection of Embryos 
After successful euthanasia of the pregnant mice, the peritoneum is snipped at the lower 
abdominal area and pulled back. The embryos will be extracted from the abdominal cavity and 
inserted into a tube of PBS for preservation until further processing takes place. After assuring 
that there are no more embryos present in the mother mice, the corpse is discarded properly 
following IACUC guidelines. 
Genotyping 
After embryos are collected, genotyping will take place in a timely manner. The tails of 
the embryos will be used for genotyping to identify the two experimental groups, Osr1 KO 
genotype embryos and Osr1 knockdown genotype embryos, and controls for this experiment, 
Osr1+/- genotype embryos. After the tails are removed, the embryos will be preserved in 
formalin.  
Tissue Processing 
All of the embryos will be processed and embedded in paraffin wax to later be serial-
tissue sectioned using a microtome. These slides will then be dyed with hematoxylin and eosin 
(HE staining) and analyzed for detection of any OFT alignment defects such as DORV and OA. 
Occurrence of defect will be calculated individually - within controls and within experimental 
mice that have Osr1 KO in their respective tissues.  
Statistics 
At least 3 embryos for each cell-specific Osr1 KO mice are needed to identify the 
presence of OFT anomalies, including DORV and OA. Other heart defects such as ASD, VSD, 
and AVSD will also be identified and noted. The incidence of abnormalities will be summed by 
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each group, Osr1 knockdown and KO each in the SHF cells and Shh-receiving cells and control. 
The chi-square test will be used to investigate the statistical significance of the data.  
Expected Results 
High prevalence of OFT misalignment, including DORV and OA, in mice embryos with 
Osr1 KO in SHF (Mef2cAHF : Cre) and embryos with Osr1 KO in Shh-receiving cells (Gli1: 
Cre) is expected. This is highly likely to happen due to high expression of Osr1 in SHF and the 
effect of Osr1 dosage on Hh-signaling.  
Compliance 
I have already worked with Research Compliance & Biosafety to get approval for the 
project. I have completed the CITI training course & “Working with the IACUC”. The course 
completion record can be seen in the appendix section. I have started mouse work in Dr. Linglin 
Xie’s lab since June, 2017 and gained training and experience on mouse manipulation. 
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CHAPTER III 
RESULTS 
 
Effect of Osr1 Deletion in SHF cells (Mef2cAHF : Cre) 
Mice embryos were collected at E14.5 and genotyped immediately using the tails for 
genotype identification of each embryo. Each embryo was then categorized into the control for 
genotype Osr1fl/+, or experimental mice with the genotypes Osr1fl/+Mef2ccre and Osr1fl/flMef2ccre 
for Osr1 knock down and knock out respectfully. Each slide was then examined then noted for 
identified CHD defects, such as ASD, VSD, AVSD, OA, and DORV. Refer to Figure 4 to see 
the contrast between normal phenotypes in control mice embryos and abnormalities that occurred 
in Osr1 KO mice embryos.  
Figure 4. Identified Defects in Embryos with Osr1 KO in SHF cells (Mef2cAHF : Cre). 
In the control (Figure 4.A) you can see that the atrial septum fully elongated to separate the left 
atrium and right atrium. However, in the ASD identified in the Osr1 KO in SHF (Figure 4.D), 
the atrial septum does not fully separate the two atriums making a hole present. In the control 
(Figure 4.B) you can see that the ventricular septum fully separates the two ventricles. However, 
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in Osr1 KO in SHF (Figure 4.E), the ventricular septum fails to separate the two ventricles 
leaving a hole. In the control (Figure 4.C), aorta is leaving the left ventricle. However, in the 
Osr1 KO in SHF (Figure 4.F), shows the aorta leaving the right ventricle resulting in a DORV. 
Refer to Table 1 for the raw numbers of heart defects identified among experimental mouse 
embryos with Osr1fl/+Mef2ccre and Osr1fl/flMef2ccre for Osr1 knock down and knock out 
respectively in SHF cells (Mef2cAHF : Cre) and control embryos.  
 
Table 1. Raw numbers of heart defects in mice with Osr1 KO in SHF cells (Mef2cAHF : Cre) 
and control mice. 
Groups Genotype Total # ASD AVSD OA DORV 
Control Osr1fl/+ 18 0 0 2 0 
Experimental 
Osr1fl/+Mef2ccre 6 0 0 1 0 
Osr1fl/flMef2ccre 4 1 0 0 1 
Note: Osr1fl/fl is not included as a viable control due to the both copies of Osr1 being modified.   
 
The raw data from Table 1 was then analyzed using comparing the total number of OFT 
misalignments, including OA and DORV, between the control and experimental group. The % 
penetrance was calculated using Equation 1:  
                                      %	𝑝𝑒𝑛𝑒𝑡𝑟𝑎𝑛𝑐𝑒 = +,-./	#	,1	23+	456./578498-+,-./	#	,1	6.4:/96	58	7;,<: ∗ 100                          (Eq.1) 
Refer to Table 2 for the total number of samples and OFT misalignment for each category and 
calculated percent penetrance.  
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Table 2. Percent Penetrance of OFT Alignment Defects across mice with Osr1 KO in SHF cells 
(Mef2cAHF : Cre) and control mice.  
Groups Genotype Total # OFT Alignment Defects % Penetrance 
Control Osr1fl/+ 18 2 11.11% 
Experimental 
Osr1fl/+Mef2ccre 6 1 16.67% 
Osr1fl/flMef2ccre 4 1 25.00% 
  
From these results, we found that Osr1 knockdown in SHF cells resulted in 150.0% 
higher occurrence of OFT misalignment defects compared to the study control and Osr1 KO in 
SHF cells resulted in 225.0% higher occurrence of OFT misalignment defects compared to the 
study control using equation 2.  %	𝐷𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 = %	:989-;.8C9	,1	23+	./578498-	D919C-6	58	9E:9;5498-./	45C9	%	:989-;.8C	,1	23+	./578498-	D919C-6	58	C,8-;,/	4C59 ∗ 100    (Eq. 2) 
From percent differences in OFT misalignment penetrance in Osr1 knockdown and KO 
compared to the control, you can see that depending on the degree of Osr1 expression, the % 
penetrance of OFT misalignment is affected. The less Osr1 is expressed the % penetrance of 
OFT misalignment increases. To determine this trend’s statistical significance a Chi-square test 
was utilized. Our null hypothesis (H0) and hypothesis (H1) for this X2 test were:  
H0: There are no statistical significant difference between the observed OFT 
misalignment penetrance between the control and experimental groups.  
H1:  H0 is false. 
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Due to small sample size we set the significance level as 𝛼 = 0.1. The X2 value was calculated 
using Equation 3. The subscript “c” represents the degrees of freedom calculated by subtracting 
1 from the total number of samples.  
                                     𝑋I𝑐 = Σ (2L69;M9DNOE:9C-9D)QOE:9C-9D                                        (Eq. 3) 
For Osr1fl/+Mef2ccre and Osr1fl/flMef2ccre the X2 value came out to be 0.127 and 0.5361 
respectfully. The calculated X2 value was then used to get the p-value. For Osr1fl/+Mef2ccre and 
Osr1fl/flMef2ccre the p-value were 0.72158 and 0.464069 respectfully. For both Osr1 KO and 
knockdown, the p-values were greater than 𝛼 = 0.1	, failing to reject the null hypothesis. This 
indicates that the trend observed for Osr1 knockdown and Osr1 KO is not statistically significant 
as it has a high possibility it just happened due to chance and not due to the treatments.  
Overall, the experimental data show a trend of higher penetrance of OFT misalignments with the 
degree of Osr1 expression but the X2 test indicated that the observed trend was statistically 
insignificant. However, the small sample size for the experimental mice Osr1fl/+Mef2ccre and 
Osr1fl/flMef2ccre should be noted from the table 2. Due to small sample size we cannot make a 
strong definitive conclusion.  
Effect of Osr1 Deletion in Shh-receiving cells (Gli1: Cre) 
TM induction of Cre-lox KO of Osr1 from Shh-receiving cells was conducted at E8.5 and 
E9.5, and the embryo was collected at E13.5 for data analysis. After genotyping, the embryos 
were categorized into two controls and two experimental groups, Osr1fl/+Gli1cre and 
Osr1fl/flGli1cre for Osr1 knockdown and KO respectively. In Figure 5, normal phenotypes of the 
control mice with genotype Osr1fl/+ can be seen in the top row in comparison to the abnormalities 
identified in Osr1 KO embryos with genotype Osr1fl/flGli1cre can be seen. 
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Figure 5. Identified defects in embryos with Osr1 KO in in Shh-receiving cells (Gli1: Cre).  
Note: In Figures 5A, 5B, and 5C normal phenotypes of the atrial septum, ventricular septum, and 
the aorta positioning respectfully in control embryos with the genotype Osr1fl/+. In Figures 5E, 
5F, 5G, there is ASD, VSD, and DORV present respectfully in experimental embryos with Osr1 
KO with the genotype Osr1fl/flGli1cre. In Figure 5D, a normal phenotype of the aorta being fully 
disconnected from the right ventricle when the Pulmonary trunk is connected to the right 
ventricle can be seen. However, in Figure 5H, a different view of DORV presented in Figure 5G 
can be seen from the aorta being connected to the right ventricle when the pulmonary trunk is 
leaving the right ventricle.   
Refer to Table 3 for the raw numbers of heart defects identified among experimental mice 
with Osr1fl/+Gli1cre and Osr1fl/flGli1cre for Osr1 knock down and knock out respectively in Shh-
receiving cells (Gli1: Cre) and control embryos.  
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Table 3. Raw numbers of heart defects in mice with Osr1 KO in Shh-receiving cells (Gli1: Cre) 
and control mice.  
Groups Genotype Total # ASD AVSD OA DORV 
Control Osr1fl/+ 18 0 0 2 0 
Experimental 
Osr1fl/+Gli1cre 5 0 0 0 1 
Osr1fl/flGli1cre 6 0 0 0 3 
Note: Osr1fl/fl was not included in the control category due to the both alleles of Osr1 being 
modified. 
 
The raw data from Table 3 was then analyzed by comparing the total number of OFT 
misalignments, including OA and DORV, between the control and two experimental groups. The 
% penetrance was calculated using Equation 1. Refer to Table 4 for the total number of samples 
and OFT misalignment for each category and calculated percent penetrance.  
 
Table 4. Percent Penetrance of OFT alignment defects across mice with Osr1 KO in Shh-
receiving cells (Gli1: Cre) and control mice.  
Groups Genotype Total # OFT Alignment Defects % Penetrance 
Control Osr1fl/+ 18 2 11.11% 
Experimental 
Osr1fl/+Gli1cre 5 1 20.00% 
Osr1fl/flGli1cre 6 3 50.00% 
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From these results, we calculated that Osr1 knockdown in Shh-receiving cell had 180% 
higher occurrence of OFT misalignment defects compared to control and Osr1 KO in Shh-
receiving cells had 200% higher occurrence of OFT misalignment defects compared to the study 
control using equation 2. From percent differences in OFT misalignment penetrance in Osr1 
knockdown and KO compared to the control, you can see the that depending on the degree of 
Osr1 expression, the % penetrance of OFT misalignment is affected. The less Osr1 is expressed 
the % penetrance of OFT misalignment increases. To determine this trend’s statistical 
significance a Chi-square test was utilized. The null hypothesis (H0) and hypothesis (H1) for this 
test are the same as the ones used in the X2 test performed earlier. Due to small sample size we 
set the significance level as 𝛼 = 0.1. The X2 value was calculated using Equation 3. For 
Osr1fl/+Gli1cre and Osr1fl/flGil1cre the X2 value came out to be 0.2726 and 4.1263 respectfully. 
The calculated X2 value was then used to get the p-value. For Osr1fl/+Gli1cre and Osr1fl/flGli1cre 
the p-values were 0.601598 and 0.042221 respectfully. For Osr1fl/+Gli1cre the p-value was 
greater than 𝛼 = 0.1 thus, failed to reject the null hypothesis making the trend observed 
insignificant. For Osr1fl/flGli1cre the p-value was less than	𝛼 = 0.1, making the trend observed 
statistically significant. In summary, both Osr1fl/+Gli1cre and Osr1fl/flGil1cre had higher 
penetrance of OFT misalignments in relation to decreasing Osr1 expression, but only the Osr1 
KO with the genotype Osr1fl/flGli1cre had statistical significance. Due to small sample size we 
cannot make a strong definitive conclusion. However, the results suggest a strong involvement of 
Osr1 in Shh-signaling in its crucial activation period E8.5 and E9.5 for normal OFT alignment. 
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CHAPTER IV 
CONCLUSION 
 
Major Findings 
For both knockdown and KO of Osr1 in SHF cell and Shh-receiving cells, a higher 
penetrance of OFT misalignment was observed with decreasing Osr1 expression. However, 
using the X2 test it was found that Osr1 knockdown and KO in SHF cells (Mef2cAHF : Cre), and 
Osr1 knockdown in Shh-receiving cells showed a non-significant difference in occurrence of 
OFT misalignment for mice compared to the control. However, the X2 test showed statistical 
significance in higher penetrance of OFT misalignment, including DORV and OA, in mice 
embryos with Osr1 KO in Shh-receiving cells (Gli1: Cre). Due to small samples size, the current 
results do not allow for a strong power analysis. Overall, the current results suggest a strong 
involvement of Osr1 in Shh-signaling at E8.5 and E9.5 for OFT development.  
Future Approaches 
In order to increase the statistical significance of our study, we plan to collect at least 20 
embryos for each cell-specific Osr1 KO mice. Each cell-line will be collected from up to 10 
different litters (considering the average size being 8) in order to ensure 90% power analysis. 
Next, we aim to identify if other lineages such as myocardium myocardium (Tnt: Cre), 
endocardium (Tie2: Cre, Nfatc1: Cre), and CNC cells (Wnt1:Cre) are affected by Osr1 for OFT 
alignment due to their important roles in cardiac development. Ultimately, using the cell-lineages 
identified to be affected by Osr1 for OFT alignment, we will investigate the interaction of Osr1 
and Hh-signaling and their functional role in OFT development.   
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There is still much to be done, but this study adds additional details to the multi-gene, 
lineage, time-point regulated process of the morphogenesis of OFT alignment which is yet fully 
mapped. It is also significant as it brings us one step closer to future preventions and 
interventions that can eliminate and alleviate the suffering of people affected by CHDs.  
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